Multibaggar stock – North Eastern Cement Company

The company wants to become the fastest-growing and most competitive cement company in eastern India. 
To achieve 15 million metric tonnes of capacity by 2026.

Star Cement Limited is the leading cement company in North-Eastern India and one of the fastest-growing cement brands in West Bengal and Bihar, acquiring a strong foothold in the Indian construction industry.
Star Cement Ltd. has established itself as the most accredited brand in the region for providing high-quality cement at fair pricing.

Spread across 200 hectares of land, the company has its 1.67 million metric tonnes per annum (MTPA) integrated cement plant in a strategic location in the idyllic town of Lumshnong in Meghalaya that ensures easy availability of high-grade limestone.

In addition, the company has two grinding units: a 2 million tonnes per annum (MTPA) cement unit in Sonapur near Guwahati and another cement unit at Mohitnagar near Siliguri in West Bengal with a capacity of 2 million tonnes per annum (MTPA), thereby aggregating an installed capacity of around 5.7 MTPA.

Star Cement has gained a prominent position in the Indian construction industry for its premium-quality cement, focusing on sustainable development, to meet today’s challenging building material needs and home-building aspirations of millions of customers, supported by pioneering marketing initiatives.
Star Cement, as a brand, goes beyond manufacturing and selling its products, it also provides technical support, best-in-class home building solutions, and services to customers at all stages of the construction process, from foundation to roof.

The brand believes in strong and socially responsible corporate governance by playing a pivotal role in safeguarding the environment, promoting economic development,
strengthening livelihoods and social development and fulfilling its responsibilities towards society with consistent corporate social responsibility initiatives.

Our product range for construction includes
Ordinary Portland Cement (OPC 43-Grade) and 
(OPC 53-Grade) and Portland Pozzolana Cement (PPC),
Portland Slag Cement (PSC) and a marquee product in the value-added segment of Anti-Rust Cement (ARC)
in line with evolving customer and construction needs.
Our product range is known for competence and quality, making it an unprecedented choice for customers, engineers, dealers, and contractors.


Star Cement Limited is listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).

It is an ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, and OHSAS 18001 certified company.

Star Cement made a significant contribution and was a proud partner in the construction of numerous landmark projects.
The company made the biggest private sector investment of more than Rs. 2227 crore in the North Eastern region.
Star Cement is a proud partner in the construction of the Bogibeel Bridge, India’s longest rail and road bridge, and Dr. Bhupen Hazarika Setu, the longest bridge in India over water.

Assam

Guwahati Games Village and Stadium
Hotel Radisson Guwahati
Guwahati Inter-State Bus Terminal (ISBT)
Sun Pharma Factory
Emami Factory
Britannia Factory
Ajanta Pharma Factory
Century Ply Factory
ITC Factory
Guwahati New Airport Terminal Building
Tezpur University
Indian Statistical Institute, Tezpur
Dibrugarh Airport New Terminal Building
Dabur Factory, Tezpur
Royal Global University, Guwahati
Berger Paints Factory at Naugaon
National Institute of Technology (NIT), Silchar
NTPC, Salakati
Indian Institute of Technology (IIT) Guwahati
NHAI: Kokrajhar to Guwahati to Naugaon to Lumding to Haflong (around 400 km stretch)

Arunachal Pradesh

Kameng Hydroelectric Power Project
Pare Hydroelectric Power Project
Lower Subanshri Hydroelectric Power Project
National Institute of Technology (NIT)
Capital Complex Building, Itanagar (Secretariat)
Manipur
Jiribam Noney Railway Project
RIMS Imphal
Imphal Airport
Imphal-MMorey International Highway Project

Tripura

Agartala Airport Parking Bay and the New Terminal Building
Agartala Railway Station
Agartala-Silchar Railway Route
Agartala Secretariat
Agartala Flyover
Palatana Power Project

Plants : 

LUMSHNONG, MEGHALAYA

Our state-of-the-art cement plant is located in the idyllic town of Lumshnong and is spread over 200 hectares of land.
The plant is strategically positioned in Meghalaya, close to its mines that produce India’s finest lime stones, ensuring very high-quality cement. 
Star Cement has its 1.67 million tonnes per annum (MTPA) integrated grinding unit,
equipped with state-of-the-art  German technology.
The plant is the largest in north-eastern India.
The company also has a clinker capacity of 2.8 million tonnes per annum (MTPA) and 51 MW of captive power generation facilities.
The cement plant boasts a 24-hour automated camera in the burning zone, an automatic rotopacker machine, and a technologically advanced dry process rotary.
It is fully automatic, and the systems are controlled by a team of experts through supercomputers in the Central Control Room (CCR), situated at the heart of the plant.
This ensures minimal variations in the quality of the cement being produced.
Emphasis on quality has garnered Star Cement international certifications, including ISO 9001:2008, ISO 14001:2004, and OHSAS 18001.

SONAPUR-GUWAHATI, ASSAM

The production of the Lumshnong plant is supplemented by that of stand-alone grinding units at Sonapur, near Guwahati.

Set up in 2013, equipped with cutting-edge technology, the grinding unit in Sonapur has a capacity of 2 million tonnes per annum (MTPA).

MOHITNAGAR JALPAIGURI, WEST BENGAL

Commissioned in 2021, Star Cement’s Grinding Unit in Mohitnagar near Jalpaiguri town, in addition to cement manufacturing units in Lumshnong in Meghalaya and Sonapur near Guwahati, has augmented cement manufacturing capacity to 5.7 million tonnes per annum (MTPA).
Spread over 45 acres, Siliguri Grinding Unit is a greenfield project set up with the latest state-of-the art German technology and has a capacity of 2 million metric tonnes per annum

Expansion plan :

Source of information : https://www.starcement.co.in/

Company Name in BSE : Star Cement

Cmp : 143 (09.06.2023)

52 Weeks High/Low : 148/81.50 (24.08.2021)

Target : – 220-350++

Time Period : 3 Months to 2 years

STUDY PURPOSE ONLY .

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information.

Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.

Update : Stock Doubled in Just 18 Months

Stock Prices Up for 100% ++ In Just 18 Months Safely .All Short Term Targets Achieved Safe Traders can Book Profits .

Risky Traders Continue to Hold for Below Targets.

Stock Name : Godfrey Phillips India.

Short Term Targets : 1800 – 200 + Possible .

Long Term Targets : 2800 – 3500++ possible .

Here is our Previous Post Link.

Study Purposes Only .

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities.

All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website.

Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information.

Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed.

No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

This is my personal thoughts on this company and not at all a buy recommendation. Do Your own due diligence /consult a SEBI registered advisor before any action.

Vedant Fashions Ltd

Company aims to expand its reach with 1000 exclusive store including 250 flagship & 50 global stores at 300 cities across India and abroad.

COMPANY PROFILE :

Our products include men’s ethnic and celebration wear items such as Indo-western, sherwanis, kurtas, jackets and accessories such as jutti, safa, mala, and women’s ethnic and celebration wear items such as lehengas, sarees, stitched suits, gowns and kurtis.

Under the umbrella of Vedant Fashions Limited (formerly known as Vedant Fashions Pvt. Ltd.) and paving the path for a happier family, the brand introduced Mohey, Indian wedding and celebration wear for women, in 2015 and acquired one of the biggest fashion brands in southern India, Mebaz, in 2018, a one-stop heritage brand catering to the entire family, with an established presence in the states of Andhra Pradesh and Telangana.

Timeless and iconic attires have cemented Manyavar’s reputation across the world with a commanding retail presence of 600+ stores in over 200 cities and in 3 countries with 11 international stores in U.A.E & U.S.A.

We believe we have developed a strong brand identity through effective brand advertising with distinct targeted marketing campaigns through a variety of media such as digital and social media, billboards, multiplex cinemas, television, and live events. For such marketing campaigns, our brand ambassadors have included leading individuals from the sporting and film industries.

To share, celebrate and evolve the Manyavar movement. A reflection of Manyavar Ravi Modi’s grit, a global vision and a nurturing spirit, the creative spark of Manya Shilpi Modi, our Chief Visualizer of merchandise and design, together with sales, production and operation groups. Together we are driven by a collective mission: to be an authority in Celebration Wear.

Manyavar envisions leading the category towards a global perspective, beyond cultural and ethnic sensibilities. This means new sections, new products and new concepts for the world citizen.

Creating, enhancing, nurturing, inspiring and ornamenting Respect.

It all began in a 1000 square feet office space with Rs.10,000 as capital. Manyavar was conceptualized in 1999, since then Manyavar has expanded its reach to 200+ cities in India, U.A.E, U.S.A

2007-08 saw the launch of an Exclusive Business Outlet format as Manyavar opens its first EBO outlet outside Kolkata, in Bhubaneshwar.

2010 marked the inauguration of the 100th store in Santa Cruz, Mumbai.

2011 was a highlight with the establishment of Manas Foundation, a non-profit, charitable organization dedicated to support heart surgeries in children.
In the same year, we crossed borders with the opening of our first international store in Dubai, followed by Bangladesh.

2012 Hit the 200 stores mark. India’s largest EBO was inaugurated in Karol Bagh, New Delhi. Manyavar collaborates with Indian Premier Leaugue to partner Kolkata Knight Riders.

2013  we extended our reach to more than 100 cities. The 300th store opened in Quest Mall, Kolkata. Our association with IPL grew stronger with sponsoring Kolkata Knight Riders, Delhi Daredevils, and Sunrisers Hyderabad.

2014 started on a high with the opening of our 333rd store – the grandest Manyavar store in Mumbai. We partnered Indian Super League as Associate Sponsors. Our film advertisements aired across India making us a national brand.

2015 marked the opening of our 400th store in Hazrathanj, Lucknow

2016 will go down in history with the launch of our Women’s Celebration Wear label – Mohey. Launch of EBO in USA

2017 The addition of the brand Mebaz, one stop destination for family celebration wear retail chain across men’s, women’s and kid’s under one roof, accelerating the presence of the company in Southern part of India

2018 We opened our 500th store at Nagpur, Dharampet.

2019 Bollywood actors like Kartik Aryan, Ranveer Singh, and Amitabh Bachchan became the new faces of the brand

2019 Bollywood actress- Alia Bhatt became the brand ambassador of Mohey

2019 Launched 600th store in Mysore.

2019 Launch of our premium men’s wear brand- Twamev

5 countries, 160+ cities, 450+ stores and two new brands in 8 years.
It began as a dream, and the journey continues.

  • 2021-Employer Branding Award for “Best Employer Branding Award” hosted by World HRD Congress and Stars Group
  • 2021-Retail Award for the “Most Admired Retailer of the year- Marketing and Advertising campaign” granted by Mapic India
  • 2020-ET Bengal Corporate Award for “Excellence in Business Performance-Turnover between INR 300 crore and 1,000 crore” granted by Association of Corporate Advisers & Executives, Kolkata and the Economic Times
  • 2020-Global Award for Retail Excellence for “Retail Marketing Campaign of the Year #TaiyaarHokarAaiye” granted by ET Now
  • 2020-Recognised as India’s Retail Champion (Winner) in Specialty Retail by Bhartiya City Centre
  • 2020-Images Excellence Award for “Men’s Indian wear” granted by Images Fashion Awards
  • 2019-Global Award for Retail Excellence for the “Retail Marketing Campaign of the Year” granted by ET Now
  • 2019- Images Award for “Most Admired Fashion Brand of the year: Men’s Indian wear” granted by Images Fashion Awards
  • 2019- Times Business Award for the “Best Men’s Ethnic Wear Brand (East)” granted by the Times Group
  • 2019- Dare to Dream Award for “Company of the Year-Retail” granted by Zee Business
  • 2019- Indian Retail Award for “Ethnic Fashion Retailer of the Year” granted by Shop X
  • 2019 – Transforming India Retail Award for “Transformational Contribution to Indian Apparel and Retail Industry” granted by the Ministry of Textiles and the Clothing Manufacturers Association of India
  • 2018 – Images Award for “Most Admired Retailer of the Year Marketing & Promotions Campaign” granted by Images Retail Awards
  • 2017 – Images Award for “Most Admired Fashion Brand of the year: Men’s Indian Wear” granted by Images Fashion Awards
  • 2016 – Ravi Modi recognized as “Entrepreneur of the Year in Trading Business – Retailer” at the Entrepreneur Awards organized by ET Now and Franchise India
  • 2015 – Ravi Modi awarded the “Bravery and Entrepreneur Award” and Certificate of Honor as the “Top Entrepreneur of India” by the Parwaz Media Group
  • 2015 – Ravi Modi recognized as “Emerging Leader” at the CMA Management Excellence Awards
  • 2015 – ET Bengal Corporate Award for the “Highest Job Creator- Above INR 300 crore to INR 1,000 crore” granted by Association of Corporate Advisers & Executives, Kolkata and the Economic Times
  • 2015 – Recognized as the “National Retailer of the Year” at the 4th Annual Indian Retail & Indian e-Retail Awards
  • 2015 – Images Award for “Excellence in Supply Chain Management & Fulfillment” granted by Images Retail Tech Awards
  • 2014 – Award for Retail Excellence for being the “Pioneer in Ethnic Retail Business” granted by ABP News
  • 2014 – ET Bengal Corporate Award for the “Fastest Growing Company-Maximum Turnover of INR 300 crore” granted by Association of Corporate Advisers & Executives, Kolkata and the Economic Times
  • 2013 – Ravi Modi awarded for “Retail Excellence” at the Asia Retail Congress organized by ET Now
  • 2012 – Ravi Modi awarded the “Young Retailer of the Year” award at the Asia Retail Congress
  • 2012 – Ravi Modi awarded the “Jewels of Rajasthan” award presented by Maneesh Media Agency
  • 2008-2010 – Recognized as “Iconic Men’s Ethnic Brand” by Central Icons
  • 2004-2008 – Recognized as “Best Men’s Ethnic Wear Brand” by Central Icons.

Company intends to raise 3149 Crs through the IPO which will be an Offer for sale by promoters.

website : https://www.vedantfashions.com/

Brands Under vedant Fashions :

“Manyavar”, “Mohey”, “Mebaz”.

Company has delivered good profit growth of 23.5% CAGR over last 5 years.

Debtor days have improved from 182 to 143 days.

ROCE : Consistently Increasing above 33 % YOY.

Its products include men’s ethnic and celebration wear items such as Indo-western, sherwanis, kurtas, jackets, and accessories such as jutti, safa, mala, and women’s ethnic and celebration wear items such as lehengas, sarees, stitched suits, gowns, and Kurtis.

Omni Channel Network :  Company operates its business through franchise-owned exclusive brand outlets (EBOs), with the remaining by multi-brand outlets (MBOs), large format stores (LFSs), and online platforms, including its website.

Sales through stores – 90%  of FY21 sales was through its exclusive brand outlets (EBOs). It operates through 546 EBOs which are operated on the basis of lease or franchisee, 145 large format stores (LFS), and 825 multi-brand outlets (MBOs). Almost 300 of its EBOs are franchisees in India and 11 EBOs overseas across the United States, Canada, and the UAE.

Online network : It operates through its own website, mobile application, and leading e-commerce platforms. Sales to customers from its online channel rose from Rs. 83m for FY19 to Rs187m in FY21. Also, EBOs can place orders for any products, not in stock and requested by customers; as a result, the company can service customers’ orders at short notice at the EBOs of their choice.

Advertisement: In FY20 company spent 8% of its sales towards advertisement and is one of the sponsors of Kolkata Knight Riders, Delhi Daredevils, and Sunrisers Hyderabad and several Bollywood stars including Kartik Aryan, Ranveer Singh, and Amitabh Bachchan became the new faces of the brand.

The company has built a strong brand identity through effective advertising with targeted marketing campaigns through a variety of formats such as digital and social media, billboards, multiplexes, etc.

Manyavar : (80% of revenues) is their flagship brand, is in the mid-premium Indian wedding and celebration-wear price range with a comprehensive product range.

Twamev : is their premium brand in men’s Indian wedding and celebration wear, is priced between Manyavar and other luxury boutique brands.

Manthan : is their value brand offering Indian wedding and celebration wear clothing for men. Following a refreshed launch in 2018, products are sold primarily through MBOs, LFSs, and online platforms. Management expects to cater to the sizable number of mid-market weddings and other celebrations through this brand.

Mohey : is their mid-premium flagship women’s brand, launched in 2015, and is the largest brand (by number of stores in FY20) across India, focusing on women’s Indian wedding and celebration wear. It offers a range of attires (lehengas, sarees, gowns), aiming to establish a leading position as Manyavar in men’s Indian wedding and celebration wear.

Mebaz : is a established one-stop-shop, heritage brand with a strong legacy, acquired in FY18. In FY21, it was strong in Andhra Pradesh and Telangana.

Product Offerings:  Its products include men’s ethnic and celebration wear items such as Indo-western, sherwanis, kurtas, jackets, and accessories such as jutti, safa, mala, and women’s ethnic and celebration wear items such as lehengas, sarees, stitched suits, gowns, and Kurtis.

Supply Chain : Large portion of manufacturing process is carried out by third-party manufacturers. However, it retains control of manufacturing by ensuring that at various stages of production, incl. design conceptualization and finalization, fabric procurement, work allocation, quality control, testing, and review of the allocation of job orders are managed by it.

Co. has in-house manufacturing processes (cutting, embroidery, stitching, and finishing). It also has ~0.26m sq. ft. central warehouse at Kolkata that houses all its finished products.

Company Name : Vedant Fashions Limited

Cmp : 1431.00 (on 29.10.2022)

52 Weeks High/low : 1502/790.

Target : 2500-4500 ++

Time Frame : 3 Years to 5 Years

Based on Technical Charts

Source of Data :

https://vedantfashions.com/

https://www.screener.in/

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

Consistent Dividend Paying Company

Founded by two Scotsmen, Stephen George Balmer and Alexander Lawrie, in Kolkata, Balmer Lawrie & Co. Ltd. started its corporate journey as a Partnership Firm on 1st February 1867. Traversing the 155 years gone by, today Balmer Lawrie is a Miniratna – I Public Sector Enterprise under the Ministry of Petroleum and Natural Gas, Govt. of India, with a turnover of Rs. 2105 crores and a profit of Rs. 170 crores. Along with its four Joint Ventures and one subsidiary in India and abroad, today it is a much-respected transnational diversified conglomerate with presence in both manufacturing and service sectors. Balmer Lawrie is a market leader in Steel Barrels, Industrial Greases & Specialty Lubricants, Corporate Travel and Logistics Services. It also has significant presence in most other businesses, it operates, viz, Chemicals, Logistics Infrastructure etc. In its entire years of existence, Balmer Lawrie has been successfully responding to the demands of an ever changing environment, leveraging every change as an opportunity to innovate and emerge a leader in industry.

Today Balmer Lawrie has eight business units – Industrial Packaging, Greases & Lubricants, Chemicals, Travel & Vacations, Logistics Infrastructure, Logistics Services, Cold Chain and Refinery & Oil Field Services with offices spread across the country and abroad.

Joint Venture in India
Balmer Lawrie – Van Leer Ltd.
AVI-OIL India Pvt. Ltd.
Joint Venture Abroad
PT. Balmer Lawrie Indonesia
Balmer Lawrie (UAE) LLC
Subsidiary
Visakhapatnam Port Logistics Park Limited

History :

Driven by the spirit of entrepreneurship, two enterprising Scotsmen Stephen George Balmer and Alexander Lawrie sowed the seeds of this company at Kolkata on 1st February, 1867. History goes…a coin was tossed…Balmer won…Balmer’s name preceded in the Firm incorporated and thus was born Balmer Lawrie.

There was hardly any business where Balmer Lawrie did not delve into in its formative years, whether it was from Tea to Shipping, Insurance to Banking or Trading to Manufacturing. The company has left a mark of its own at every step of its remarkable corporate journey.

Today, Balmer Lawrie is a Mini-Ratna-I Public Sector Enterprise, under the Ministry of Petroleum & Natural Gas of India. It has eight Strategic Business Units – Industrial Packaging, Greases & Lubricants, Chemicals, Travel & Vacations, Logistics Infrastructure, Logistics Services, Cold Chain and Refinery & Oil Field Services, with offices spread across the country and abroad. Balmer Lawrie has grown enormously in the last 155 years and has become the market leader in Steel Barrels, Industrial Greases & Specialty Lubricants, Corporate Travel and Logistics Services. It has very well responded to the demands of an ever changing environment and has taken full advantage of every opportunity to innovate. Balmer Lawrie also grew inorganically through various JVs over the period of time.

Company Is almost Debt Free .

It Maintains Healthy Dividend Payout 81.78% .

ROCE : Decreasing YOY .

All Information is For Study Purposes Only .

Company Name : Balmer Lawrie & Company ltd .

CMP : 109/- ( On 17.07.2022)

52 Weeks High/Low : 103.20/145.50 .

Target : Short Term (6 Months ) : 125 to 145 ++

Expected to Give Good Dividends this Year also .

Based on Technical Charts

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

Update: Dr Lal Pathlabs Ltd

Stock Given on 14.04.2021 @ 2400 to 2800 . Now Stock Price Trading at same Buy Price Zone at 2821 .

Stock Made a High on 4200 in the Month On 16.09.2021 Given 50 % Returns In Just 6 Months . Made a Low 2720 to High 4209 /-.

Now Back to Same Buy Range In Recent Corrections @ 2820 /-

New Investors or Traders Can Buy at 2550 to 2800 Range can be Best Buy.

Existing Investors Who Bought Earlier For Long Term can Hold Further also . Take Correction as Advantage and Continue To Buy & Hold Further also .

Here is Our Link for Previous Article .

TARGETS : 3800 – 4350 – 8000++

BASED ON : FUNDEENTALS OF THE COMPANY .

ALL ARE FOR STUDY PURPOSES ONLY .

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website.

Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed.

No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

DIVI’S LABORATORIES LTD IN GENERIC API COMPANY

It’s engaged in manufacturing of Advanced Pharmaceutical Ingredients (APIs), Intermediates and Nutraceutical ingredients with predominance in exports. It has a market presence in 95 countries and 17,000 employees ,31 Years In Industry and is one of the leading pharmaceutical companies in the world.

Divi’s is recognized as a ‘Reliable Supplier of generic APIs (Active pharmaceuticals ingredients)’ and a trustworthy ‘Custom Manufacturer’ to Big Pharma and also is among the top API manufactures in the world.

Divi’s is the leading manufacturer of APIs(Active pharmaceuticals ingredients), Intermediates and Registered starting materials offering high quality products with the highest level of compliance and integrity to over 95 countries.

Divi’s recently reached the milestone of being one among the top 3 API manufacturers in the world and one among the top API companies in Hyderabad.

Divi’s is a Public limited company listed on the Indian stock exchange with a revenue of INR ~7050 crores (~$960M) for the year 2020-21

Advanced manufacturing facilities both in Hyderabad and Vizag have been inspected multiple times by USFDA, EU GMP (UK, Slovenia, German, Irish authorities), HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS health authorities.

We envision creating value for all stakeholders by manufacturing high quality Generic APIs, Custom synthesis of APIs & Intermediates along with Nutraceutical Ingredients to the Global Pharmaceutical & Nutraceutical industry through sustainable leadership in chemistry.

We at Divi’s aim to be a responsible business, adding value through our core competency in the area of chemistry while adhering to our core values and serving the immediate community and at large through our diverse social initiatives that would establish a strong foundation for a better tomorrow for all stakeholders.

The company is engaged in production of leading generic APIs, Nutraceutical ingredients and custom synthesis of APIs and intermediates for global companies.

It has a product portfolio of 122 products across various therapeutic areas.

The company derives 47% of total revenues from top 5 products. Naproxen (an anti-inflammatory drug)

contributed 18% of total sales during FY20. The company is one of the leading suppliers of this drug.

Geographical Revenue Breakup
The company derives 85% of total revenues from exports.
Presently, it earns 47% of revenues from Europe, followed by America (23%), India (15%), Asia (11%) and rest of world (4%).


The revenue share of America has gone down from 33% . In FY17 to 23% in FY20 while the revenue share of Europe has gone up from 40% to 47% in same time frame implicating larger growth from its European Business.

R&D
The company has 3 R&D facilities near its manufacturing locations. These centers are involved in development of processes for both new compounds and improvement of processes for compounds on the market.
It spent ~38 crores towards R&D in FY20 as compared to ~35 crores in FY19.
The cost fluctuates depending on R&D operations, it spent ~43 crores towards R&D in FY17.

Manufacturing Capabilities
The company has 2 manufacturing locations at Bhuvanagiri, Karnataka and Visakhapatnam, Andhra Pradesh. These 2 manufacturing locations houses 6 different manufacturing units with diverse operations.

The company has started construction of its new manufacturing facility in Kakinada, Andhra Pradesh in Dec 2020.
The company will invest 1,500 crores from internal accruals and the operations are likely to commence within 12-18 months for phase-1 of the project.

Subsidiaries
The company has 2 wholly owned subsidiaries
Divis Laboratories (USA) Inc, Europe AG in Switzerland which are engaged in marketing/ distribution of nutraceutical products to provide greater reach to customers within these regions.
The subsidiaries brought 319 crores (6%) of revenues for the company in FY20.

LEADERSHIP :

Our Leadership team includes many members of the Senior Executive team that are well supported by a very diversified team of Board of Directors.

Both the teams are accountable to our shareholders for the responsible conduct of the business and our long-term success. They also represent the interests of all our stakeholders in ensuring that we deliver quality products by putting science at the heart of everything we do.

Leadership team along with the Board of Directors are responsible for the direction, strategy, execution and administration of the company.

The Board comprises of twelve members with Dr. Ramesh B.V. Nimmagadda as Chairman.Under the leadership of Dr. Divi, the Leadership team is responsible for overseeing the business operations. Members of the Leadership team and their biographies are shown below.

Dr. Murali K. Divi (Managing Director)

Dr. Divi is the Founder and Managing Director of Divi’s Laboratories Ltd. Dr. Divi oversees major technical and financial operations of the company.

Prior to starting Divi’s, Dr. Divi had extensive experience of over 15 years in the Pharma industry and has led various Research and Manufacturing teams globally. He holds a Ph.D. degree in Pharmaceutical Sciences from Kakatiya University, India. He is also a member of the American Institute of Chemical Engineers and the American Chemical Society.

Mr. N.V. Ramana

Executive Director

Mr. Nimmagadda is the Executive Director of Divi’s Laboratories Ltd and has been with Divi’s for the past 25 years. In his role, he oversees all functions of Strategic planning, Sales and Marketing, Custom Manufacturing, Contract research and Nutraceutical ingredients development.

Prior to joining Divi’s, Mr. Nimmagadda had over 10 years of experience in the Pharmaceutical industry and was instrumental in enhancing business development for several pharma companies. He is a graduate in chemistry from Osmania University, India. He is also a Member of the American Chemical Society.

Dr. Kiran S. Divi

Whole-Time Director & Chief Executive Officer

Dr. Kiran Divi is the Director on Board & Chief Executive Officer at Divi’s Laboratories Ltd and has been with Divi’s for the past 20 years. He officially took on the role of leading Divi’s as the CEO, starting January 2020. He oversees all the Corporate functions and Operations at our manufacturing facilities. Under his direction, Divi’s has been developing high quality business strategies and plans ensuring their alignment with the short term and long term objectives.

Prior to joining Divi’s, Dr. Divi has gained extensive knowledge and understanding of the Pharmaceutical Industry with an extra focus on the US Generic Market. He has a post-graduate degree in Pharmacy from JNTU, India. He holds a Ph.D. degree from Gandhi Institute of Technology and Management, Visakhapatnam.

Mr. Madhusudana Rao Divi

Whole-Time Director (Projects)

Mr. Rao Divi is the Director of Projects at Divi’s Laboratories Ltd and has been with Divi’s for the past 20 years. He administers all aspects of manufacturing including production, engineering, sustainability and environmental management along with construction of new projects.

Prior to joining Divi’s, Mr. Rao Divi had executed several engineering construction projects and was closely involved in implementing numerous offshore and onshore constructions in India and globally. Mr. Rao Divi has a post-graduate degree in Structural Engineering from Mysore University, India.

Ms. Nilima Prasad Divi

Whole-Time Director (Commercial)

Ms. Nilima is the Director on Board – Commercial at Divi’s Laboratories Ltd and has been with Divi’s for the past 5 years. She administers all aspects of Material Sourcing and Procurement, Corporate Finance and Investor Relations.

Prior to joining Divi’s, Ms. Nilima has gained extensive commercial acumen and familiarity with material requirement planning and financing. Ms. Nilima has a Master’s Degree in International Business from Gitam Institute of Foreign Trade, India and Masters in International Finance from Glasgow University, U.K.

Company Is almost Debt Free .

It Maintains Healthy Dividend Payout Company .

ROCE : 32% in 2021 .

Promoters Holding Is More than 51.95 % .

” In Recent Correction Stock Price is Available at Very Cheap Valuations . If Once Markets Starts Recovering its Will Gain Very Fast . Take Price as Advantage and Buy at per Your Risk “.

If Any New Investors Wants To Open New Demat Account Click on this Link  .

Like Our Facebook Page .

All Information is For Study Purposes Only .

Company Name : DIVI’S LABORATORIES LTD .

CMP : 3941/- ( On 30.01.2022)

Target : Short Term (6 Months to 1 Year ) : 4800 – 5,400/++ .

Long Term (2 – 5 Years of Time Frame ) : 8,500 – 10,300 ++

Based on Technical Charts

Source of Data : https://www.divislabs.com/ & https://www.screener.in/

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

Right Time To Take Entry In This Pharmaceuticals Company

In our Previous Posts We Have Already mentioned about this stock . But again we are Going to Suggest This Stock Due to Its Returns Given in Last 8 Months @ 60 % ++ Returns With In 1 Year.

Click Here for Previous Post .

Stock Trading at 2019 PE at 47.60 Which is Very Cheap and Giving very Good Opportunity For entry .

This Stock is Very Good for Both short Term & Long Term also .

Preferable for Both Short Term & Long Term Investors also .

Company is almost Debt free .

Very Good Dividend Paying Company Year On Year Basis .

ROCE % From Past 10 Years is above 34 % which is Excellent .

Promoters Holding Is More than 74 % .

Risk Free Company – Instead of Buying Less Priced or More Taking More Risk Stock its Better to Buy Such Stock is Better as per My View .

If Any New Investors Wants To Open New Demat Account Click on this Link  .

Like Our Facebook Page .

All Information is For Study Purposes Only .

Company Name : ABBOTT INDIA .

CMP : 16065/-

Best Buy at : 14,900 – 15,800 .

Target : Short Term (6 Months to 1 Year ) – 18,000 – 20,200/++ .

Long Term (2 – 3 Years of Time Frame ) : 22,000 – 24,000 ++

Note : It Will always Gives Good Time to Enter .

Based on Technical Charts

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

Update : ABBOTT INDIA

Congratulations To All – Stock Given 60 % Returns in Just 8 Months . Initially Given on 02.02.2021 at 14300 /- stock Touched New High & achieved Both Short Term & Long Term Targets on 04.10.2021 @ 23,934/- But We mentioned as Final Target as 22,800/- . Hope Every One Booked Profits Earlier .

Within A span of 8 Months It achieved Targets . Closed in 2021 Itself .

Click Here for More Details .

If Any New Investors Wants To Open New Demat Account Click on this Link  .

Like Our Facebook Page .

All Information is For Study Purposes Only .

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

TATA ELXSI Stock Update : Stock Given 150 % Profits in Just 8 Months

Congratulations to All who Bought Shares Safe Investors Can Book 50 % Profits Here & Hold Remaining Qty as Free of Cost for Long term . Expecting More Upside Risky Holders Can Hold Further for More New Highs in Coming Days Also.

Click Here to See Our Previous Post .

If Any New Investors Wants To Open New Demat Account Click on this Link & Share Your Details with Us If Interested .

Our Facebook Page

All Information is For Study Purposes Only .

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information. Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk.

Update : PENNY STOCK IN SUGAR SECTOR GIVEN 350% IN JUST 11 MONTHS

Congratulations To all Penny Stock Given 360 % Up In Just 11 Months . Stock Touched 52 New High @36.70/- On 05.01.2022 . ALL ARE FOR STUDY PURPOSES ONLY.

To Open New Demat Account Click on this Link & Share Your Details with Us .

Disclaimer: I am Not a SEBI REGISTERED ANALYST. This Website & Its Owner, Creator & Contributor is Neither a Research Analyst nor an Investment Advisor and Expressing Option Only as an Investor in Indian Equities. All trading strategies are used at your own risk.

He/ She are Not Responsible for any Loss a Rising out of any Information, Post or Opinion Appearing on this Website. Investors are advised to do Own Due Diligence or Consult Financial Consultant before acting on Such Information.

Author of this Website not providing any Paid Service and not Sending Bulk mails/SMS to Anyone. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted. Investment/Trading in securities Market is subject to market risk. This is my personal thoughts on this company and not at all a buy recommendation. Do own due diligence /consult a SEBI registered advisor before any action.